Skip to content

There are over 45,000 medical cannabis patients in the UK. Find out if you qualify

  • Patient Guide Coming Soon
Medical Cannabis Patients Hub
  • About
  • contact
  • Articles
  • Strains
  • Cannabinoids
  • Terpenes
Menu
  • About
  • contact
  • Articles
  • Strains
  • Cannabinoids
  • Terpenes

CBG

Cannabigerol Cannabinoid
Chemical Structure: Cannabigerol (C₂₁H₃₂O₂)
Therapeutic Uses: Analgesic (pain relief), anti-inflammatory, neuroprotective properties, potential anticancer (inhibits tumor growth), antibacterial, appetite stimulant, potential treatment for glaucoma, mood enhancement.
Legal Status: Legal in the UK when derived from approved sources and contains less than 0.2% THC.
Cannabigerol (CBG) is a cannabinoid known as the “mother of all cannabinoids” because it acts as a precursor to other cannabinoids in the cannabis plant. Found in lower concentrations in mature plants, CBG is gaining attention for its potential therapeutic uses without the psychoactive effects associated with THC. Its potential benefits include pain relief, anti-inflammatory properties, and neuroprotective effects, making it a subject of interest in ongoing cannabis research.

Detailed Cannabinoid Information

Introduction – About Cannabigerol (CBG)

CBG stands for cannabigerol, a lesser-known cannabinoid compared to its famous counterparts, THC and CBD. Cannabigerol (CBG) is often referred to as the “mother of all cannabinoids” because it is the precursor from which other cannabinoids are synthesized in the cannabis plant. This non-psychoactive compound is found in lower concentrations than THC and CBD.

Chemical Structure and Interaction

The chemical formula for CBG is C₂₁H₃₂O₂. It interacts with the body’s endocannabinoid system by binding to both CB1 and CB2 receptors, potentially enhancing the neurotransmitter anandamide, which plays a role in enhancing pleasure, regulating appetite, sleep, and alleviating pain.

History and Discovery

CBG was first discovered in 1964 as one of the many cannabinoids found in the cannabis plant. It has since been studied for its potential medicinal benefits, although it remains less researched than THC and CBD.

Legal and Regulatory Status in the UK

In the UK, CBG falls under the same regulations as CBD, which means it is legal provided it contains less than 0.2% THC. However, products containing CBG are subject to strict controls and must meet safety standards before they can be sold.

Methods of Consumption

CBG can be consumed in various forms including oils, tinctures, and topical applications. It is also available in more concentrated forms such as isolates and distillates.

Pharmacokinetics

Like other cannabinoids, CBG is metabolized in the liver by enzymes. The bioavailability of CBG may vary depending on the method of consumption, with inhalation providing a more direct route into the bloodstream compared to ingestion.

Clinical Applications in the UK

Although research is in its early stages, CBG is being explored for its potential to treat conditions such as glaucoma, inflammatory bowel disease, and certain types of cancer. However, more high-quality studies are needed to fully understand its effectiveness and therapeutic properties.

Adverse Effects

The potential side effects of CBG are generally considered mild and may include dry mouth, mild sedation, or gastrointestinal discomfort. Like all cannabinoids, it should be used with caution, particularly in individuals with underlying health conditions or those taking other medications.

  • Our resources are here to help!

New Patient?

Check Your Eligibility →

Want to Know About Cannabis Clinics?

  • Coming Soon

Is Medical Cannabis for You?

  • Coming Soon

© MCPH UK | Green Creative 2024. All right reserved.

  • Facebook Group
  • Twitter